CDH1 and prostate cancer: Human prostate cancer cells overexpressing δ-catenin show an increase in multi-layer growth and substantial processing of plasma membranous E-cadherin, suggesting that δ-catenin plays a role in prostate cancer progression by inducing E-cadherin processing and thereby the release of β-catenin and increased oncogenic signaling5.